Senior insider sale
CEO and Chairman at CADRENAL THERAPEUTICS, INC. — senior position signals high conviction
$252.3K
18K shares
PHAM QUANG X plans to sell 18K shares of CADRENAL THERAPEUTICS, INC. valued at approximately $252.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Founders Shares
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/25/2022 | Founders Shares N/A | 1.80K | — |
| Total | 1.80K | ||
Completed
Units to sell
500.00
Market value
$7.1K
Units to sell
881.00
Market value
$12.3K
Units to sell
419.00
Market value
$5.9K
Units to sell
6.79K
Market value
$95.7K
Units to sell
2.58K
Market value
$36.1K
Units to sell
1.19K
Market value
$16.5K
Units to sell
3.84K
Market value
$53.5K
Planned — Approximate Date
Units to sell
1.80K
Market value
$25.2K
Units
18K
Value
$252.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/2/2025 | 500.00 | $7.1K | — | Completed |
10/1/2025 | 881.00 | $12.3K | — | Completed |
9/29/2025 | 419.00 | $5.9K | — | Completed |
9/25/2025 | 6.79K | $95.7K | — | Completed |
9/24/2025 | 2.58K | $36.1K | — | Completed |
8/28/2025 | 1.19K | $16.5K | — | Completed |
8/27/2025 | 3.84K | $53.5K | — | Completed |
| Planned — Approximate Date | ||||
10/9/2025 | 1.80K | $25.2K | NASDAQ | Planned |
| Total | 18K | $252.3K | ||